Filing Details

Accession Number:
0001127602-14-016732
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-07 18:16:32
Reporting Period:
2014-05-05
Filing Date:
2014-05-07
Accepted Time:
2014-05-07 17:16:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
859737 Hologic Inc HOLX X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) 042902449
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181190 P Glenn Muir 35 Crosby Drive
Bedford MA 01730
Executive Vp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-05 96,000 $14.50 911,306 No 4 M Direct
Common Stock Disposition 2014-05-05 96,000 $22.98 815,306 No 4 S Direct
Common Stock Acquisiton 2014-05-06 100,000 $15.75 915,306 No 4 M Direct
Common Stock Disposition 2014-05-06 100,000 $23.58 815,306 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2014-05-05 96,000 $0.00 96,000 $14.50
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2014-05-06 100,000 $0.00 100,000 $15.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-11-13 No 4 M Direct
236,060 2016-11-11 No 4 M Direct
Footnotes
  1. The transaction reported herein reflects an aggregate of sales at prices ranging from $22.57 and $23.19, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares purchased at each separate price.
  2. The transaction reported herein reflects an aggregate of sales at prices ranging from $23.26 and $23.70, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares purchased at each separate price.
  3. The option becomes exercisable in five equal annual installments beginning November 13, 2009
  4. The option, issued pursuant to the 2008 Equity Incentive Plan, becomes exercisable in five equal annual installments beginning November 11, 2010.